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| INTRODUCTION
We report a second case of Apert syndrome in monozygotic twins affected by the same mutation but with different clinical characteristics. The typical malformations were identified for both fetuses. In addition, fetus A presented a congenital left diaphragmatic hernia and a cleft palate.
Apert syndrome is an acrocephalosyndactyly characterized by craniosynostosis, midface hypoplasia, and extremities anomalies and caused by heterozygous mutation in the Fibroblast Growth Factor 2 (FGFR2) gene. The estimated incidence of Apert syndrome is reported to be 1/100 000 to 1/160 000. 1 We report a case of a prenatal diagnostic of Apert syndrome in monozygotic twins affected by the same mutation but with different clinical characteristics.
| CASE HISTORY
This is a second pregnancy in a 32-year-old woman without medical or familial history. The antenatal diagnostic of Apert syndrome was made at 30 weeks of gestation during a detailed ultrasound (US) investigation. The typical malformations were identified by two-(2D) and three-dimensional (3D) US for both fetuses: facial dysmorphia including: hypertelorism, midface hypoplasia, craniosynostosis with brachycephaly, micrognathia, down-slanting palpebral fissures (Figures 1 and 3) , and symmetric limbs' extremities abnormalities (mitten hand, enlarged and varus big toe) of the four extremities (Figures 2 and 3 ). In addition, fetus A presented a congenital left diaphragmatic hernia and a cleft palate ( Figure 3 3 In these two reports, both fetuses had the same genetic heritage (S252W mutation) but a different phenotypic expression of Apert syndrome, suggesting, for example, the influence of epigenetic phenomena. In the previously published case, the craniostenosis was different between the two fetuses, whereas in our description, the twins' skull's structures were similar and only visceral abnormalities were different. The correlation between genotype and phenotype is not clearly established in FGFR2 mutation. According to the review of 26 patients with S252W mutation made by Park et al, phenotypic expression is variable, all of the patients had a craniosynostosis, hypertelorism, midface hypoplasia, a hand or a foot syndactyly. Only 15 of them had cleft palate, 14 had a central nervous system abnormalities, four had a cardiac defect, and three had urogenital abnormalities. 4 S252W mutation was implicated already in two patients associated with congenital diaphragmatic hernia. 5, 6 A third report of a patient with Apert syndrome in association with congenital diaphragmatic hernia was described with P253R mutation of FGFR2. 6 Further studies of this rare disease may help to improve the knowledge on the phenotypic expression of S252W mutation. Animal model may also help to understand pathogenesis: Nitrofen model in rat with congenital diaphragmatic hernia provide evidence that FGFR2 is playing an active role in fetal lung development. For these twins, Apert syndrome was highly suspected before molecular genetic testing. Usually, craniosynostosis syndromes are diagnosed in the first month of newborn life. In this case, the US sign leading to a detailed US investigation was a congenital diaphragmatic hernia in one fetus of this monochorionic pregnancy. FGFR-related craniosynostosis disorders differed mainly by extremities anomalies: In Crouzon syndrome, extremities are normal, contrary to Apert and Pfeiffer syndromes. 10 Antenatal diagnostic allows being more specific on fetus' prognosis: In Crouzon syndrome, intellectual development is normal against Apert syndrome. In order to confirm the diagnosis, a targeted prenatal testing based on clinical findings may be valuable.
